A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
מצבים רפואיים
Active Immunisation for Chikungunya Virus Infection
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
All India Institute of Medical Sciences, Guwahati, Assam, India
All India Institute of Medical Sciences, Patna, Bihar, India
Contact: Principal Investigator (Sanjay Pandey, MBBS MD)All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Contact: Study coordinator (Abhiruchi Galhotra, MBBS MD) · abhiruchigalhotra@aiimsraipur.edu.in · 8518881711Contact: Principal Investigator (Abhiruchi Galhotra, MBBS MD)Redkar Hospital and Research Centre, Mumbai, Goa, India
Contact: Principal Investigator (Sagar vivek redkar, MBBS MD)PGIMS, Rohtak, Haryana, India
Contact: Principal Investigator (savita verma, MBBS MD)IMS & SUM Hospital bhubaneshwar Institute of Medical Sciences & SUM Hospital, Bhubaneswar, Odisha, India
Contact: Principal Investigator (Venkata Rao Epari, MBBS MD)Jawahar Lal Nehru medical College, Ajmer, Rajasthan, India
Contact: Principal Investigator (Sanjiv Maheshwari, MBBS MD)Sardar Patel Medical College, Bikaner, Rajasthan, India
Contact: Principal Investigator (Veer Bahadur Singh, MBBS MD)Guru Teg Bahadur Hospital, Delhi, The National Capital Territory (nct) of Delhi, India
Contact: Principal Investigator (Shiva Narang, MBBS MD)AIIMS Rishikesh Department of Community Medicine, Rishikesh, Uttarakhand, India
Contact: Principal Investigator (Mahendra Singh, MBBS MD)